Navigation Links
Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
Date:4/15/2008

AMSTERDAM, April 15 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announced today that the U.S. Food and Drug Administration (FDA) has granted its product Rhitol(TM) Orphan Drug Designation for the treatment of chronic Graft versus Host Disease (GvHD). This complication of allogeneic bone marrow transplantation is highly disabilitating and can become life threatening when the patient is unresponsive to steroid treatment. Rhitol(TM) has completed a multicenter phase I/II study for patients with severe steroid resistant chronic GvHD. A phase III study is anticipated to start in 2008.

"The decision by the FDA to grant Rhitol(TM) orphan drug designation in this area of blood cancer with unmet medical need advances our efforts to develop an innovative treatment" says Dr. Manja Bouman, Chief Executive Officer of Kiadis Pharma.

The FDA's orphan drug designation is reserved for new therapies being developed to treat diseases or conditions that affect fewer than 200,000 people in the United States. The orphan drug designation provides for an accelerated review process, tax benefits, exemption from user fees and a seven-year period of market exclusivity in the United States after product approval.

About Rhitol(TM)

Rhitol(TM) is under development as a treatment for patients with chronic GvHD resistant or intolerant to immunosuppressive agents. Rhitol(TM) treatment targets activated T cells that cause GvHD and results in immune modulation within patients with chronic GvHD, restores immune tolerance and attempts to achieve disease remission.

About chronic GvHD

GvHD is a condition that can develop after allogeneic bone marrow transplantation and resembles an autoimmune disease. Graft versus Host Disease is caused by immune cells from the donor graft attacking the patient's tissues and organs. Chronic GvHD usually develops some time after the transplantation and is generally treated by immunosuppressive drugs, such as ster
'/>"/>

SOURCE Kiadis Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... NEW PROVIDENCE, N.J. , Sept. 2, 2014 ... corporate sponsor for MassBio,s 20th Annual Golf Classic, a ... Foundation. The event will be held on September 5 ... Plymouth, Massachusetts . The MassBioEd ... Massachusetts through educational programs, workforce development, and ...
(Date:9/2/2014)... Press attending the Project LIBERTY Grand Opening ... the people and events in Emmetsburg on Sept. 3. ... the day. Additionally, we will do our best to ... as well as representatives from the local community. Any ... Please remember to RSVP to Matt Merritt (matt.merritt@poetdsm.com) to ...
(Date:9/2/2014)... Opertech Bio, Inc., a company ... effective approach to sensory evaluation, today announced the ... U.S. Patent and Trademark Office, encompassing high-throughput sensory ... “Opertech’s taste evaluation technology called Microtiter Operant Gustometer ... system for rapid characterization of taste sensory properties,” ...
(Date:9/2/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... consist of three large odour control systems for waste water ... "These orders are consistent with the market resurgence in ... President and CEO. "After a difficult period of restraint in ... to see sales growth. Our lower cost structure, technology improvements ...
Breaking Biology Technology:Linde helps fund STEM education in Massachusetts 2Linde helps fund STEM education in Massachusetts 3Press agenda for Project LIBERTY Grand Opening 2Press agenda for Project LIBERTY Grand Opening 3Press agenda for Project LIBERTY Grand Opening 4Press agenda for Project LIBERTY Grand Opening 5Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology 2
... Health, a three-hospital health system providing care ... information management system provided by Surgical Information ... seamlessly into the hospitals, existing Siemens Soarian® ... safety and drive business results. ...
... September 29, 2010 ... ... var ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... his significant and global contributions to clean water and ... his commitment to invention and the pursuit of discovery, ... degree from Stevens Institute of Technology at the university,s ... Meng, a professor in the Charles V. Schaefer, Jr. ...
Cached Biology Technology:Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 2Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 3Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 4InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 2InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 3InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 4InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 5InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 6InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 7InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 8InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 9InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 10Xiaoguang Meng receives honorary master of engineering from Stevens 2Xiaoguang Meng receives honorary master of engineering from Stevens 3
(Date:9/2/2014)... truth; everyone has a tipping point. We all want to ... benefit is great enough. Now, scientists have confirmed the area ... , The result was published online this week in ... honest, even if lying is beneficial," said Lusha Zhu, the ... Virginia Tech Carilion Research Institute , where she works with ...
(Date:9/2/2014)... Sam Kean stops by Reactions this week to debunk ... that, despite what "Shark Week" may lead you to ... http://youtu.be/KhFygIoW_MA . , Kean,s book, "The Disappearing Spoon: ... History of the World from the Periodic Table of ... 10-episode video series produced for the newly launched American ...
(Date:9/2/2014)... for eating anything, including each other, camel crickets are ... Carolina State University finds that non-native camel cricket species ... , "The good news is that camel crickets don,t ... says Dr. Mary Jane Epps, a postdoctoral researcher at ... the research. , The research stems from a chance ...
Breaking Biology News(10 mins):Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 4Researchers find Asian camel crickets now common in US homes 2
... Johns Hopkins researchers report that two proteins best known ... the liver into a sugar-producing factory when food is ... damaging problem in people with diabetes, the proteins' interaction ... the disease, the researchers say. , Under normal circumstances, ...
... the immune system uses to label foreign invaders as ... system can brand foreign proteins by chemically modifying their ... cells known as lymphocytes would recognize the trespassers and ... T cells need to see these types of modifications ...
... a close relative of the Formosan "super termite" that's ... become established in South Florida, according to University of ... pest in tropical areas such as Brazil and the ... threat to Florida until now," said Nan-Yao Su, a ...
Cached Biology News:Future diabetes drugs may target new protein interaction 2Future diabetes drugs may target new protein interaction 3Newly Discovered 'Branding' Process Helps Immune System Cells Pick Their Fights 2Newly Discovered 'Branding' Process Helps Immune System Cells Pick Their Fights 3Cousin of Asian super termite invades Florida 2
Human LT beta R/TNFRSF3 Phycoerythrin MAb (Clone 71319)...
Human Serpin A3 MAb (Clone 213907)...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Human SorCS1 Affinity Purified Polyclonal Ab Protein Family: Neurotrophins...
Biology Products: